| 000 | 01127 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518024311.0 | ||
| 264 | 0 | _c20220218 | |
| 008 | 202202s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2019.02.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaldman, Reid | |
| 245 | 0 | 0 |
_aLaboratory monitoring requirements during mycophenolate mofetil therapy for dermatologic conditions: A single-institution retrospective chart review. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _c09 2021 |
||
| 300 |
_a726-728 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aLaboratories |
| 650 | 0 | 4 |
_aMycophenolic Acid _xtherapeutic use |
| 650 | 0 | 4 | _aPrednisone |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aStrober, Bruce E | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 85 _gno. 3 _gp. 726-728 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2019.02.040 _zAvailable from publisher's website |
| 999 |
_c29405647 _d29405647 |
||